Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial Of PSI-7977 For Chronic Hepatitis C

Links shared publicly online about this topic.

  • 653
    total visits

Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial Of PSI-7977 For Chronic Hepatitis C

medicalnewstoday.com —

Pharmasset, Inc. (Nasdaq: VRUS) announced that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The t

View full resource at medicalnewstoday.com

Tags: Liver, Liver Condition, Hepatitis, Hepatitis C, Clinical Trial

  • Share

Most Recently Shared on December 16, 2010 at 4:05 am By:

mnt_pharma MNT Pharma News

Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial Of PSI-7977 For Chronic Hepatitis C http://mnt.to/3P6G

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Liver Disease MNT Liver Disease

MNT Clinical Trials MNT Clinical Trials

Advertisement